MX1 Polyclonal Antibody

This gene encodes a guanosine triphosphate (GTP)-metabolizing protein that participates in the cellular antiviral response. The encoded protein is induced by type I and type II interferons and antagonizes the replication process of several different RNA and DNA viruses. There is a related gene located adjacent to this gene on chromosome 21, and there are multiple pseudogenes located in a cluster on chromosome 4. Alternative splicing results in multiple transcript variants.

The MXI1 Polyclonal Antibody is a highly specific and sensitive tool designed for the detection and analysis of MXI1 protein expression in various biological samples. This antibody is produced using state-of-the-art technology and rigorous quality control measures to ensure optimal performance and reliability.

MXI1 is a transcriptional repressor that plays a crucial role in the regulation of cell proliferation and differentiation. It acts as a negative regulator of the MYC oncogene and is involved in the suppression of tumor growth. The MXI1 Polyclonal Antibody recognizes the MXI1 protein with high affinity and specificity, enabling accurate and precise quantification of MXI1 expression levels.

This antibody is suitable for a wide range of applications, including Western blotting, immunohistochemistry, and immunofluorescence. It has been validated for use in various species, including human, mouse, and rat, making it a versatile tool for researchers working in different fields.

The MXI1 Polyclonal Antibody is supplied as a liquid formulation in a convenient size of 100 µg. It is provided in a ready-to-use format, eliminating the need for time-consuming and complicated preparation steps. The antibody is stored at -20°C to ensure long-term stability and maintain its functionality.

With its exceptional sensitivity and specificity, the MXI1 Polyclonal Antibody is an indispensable tool for studying MXI1 protein expression and its role in cellular processes. It offers reliable and reproducible results, making it an ideal choice for both basic research and clinical applications.